Literature DB >> 20617925

Emergence and dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population.

Paul-Louis Woerther1, Cécile Angebault, Mathilde Lescat, Etienne Ruppé, David Skurnik, Assiya El Mniai, Olivier Clermont, Hervé Jacquier, Anaelle Da Costa, Magaly Renard, Régis Marc Bettinger, Loïc Epelboin, Claire Dupont, Didier Guillemot, François Rousset, Guillaume Arlet, Erick Denamur, Félix Djossou, Antoine Andremont.   

Abstract

BACKGROUND: Intestinal carriage is a key factor in extended-spectrum beta-lactamase (ESBL) infection epidemiology but is difficult to study in open communities. To overcome this problem, we studied a highly stable group of Amerindians for whom we reported an ESBL carriage prevalence of 3.2% in 2001.
METHODS: In 2006, ESBL carriage was assessed among 163 healthy volunteer adults. ESBL isolates were identified, and their molecular resistance mechanisms were characterized. Antibiotic use in the year before sampling and the epidemiological characteristics of the population were analyzed. Results were compared to those obtained in 2001.
RESULTS: In 2006, the ESBL carriage prevalence, exclusively comprising Escherichia coli, was 8.0%. It mainly consisted of CTX-M-type ESBL. The strains and plasmids carrying ESBL were heterogeneous, but 1 CTX-M-2-producing strain was found in 4.3% of the subjects analyzed. No individual risk factor was identified. However, overall antibiotic use had almost doubled since 2001. A 3-fold increase was noted for beta-lactams.
CONCLUSIONS: In this population, the frequency of ESBL increased with time because of the appearance of CTX-M ESBL, mimicking what occurs in the developed world. This resulted from the probable repeated introduction of new strains and plasmids and from interindividual dissemination. During the same period, antibiotic use substantially increased.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20617925     DOI: 10.1086/654883

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Emergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuria.

Authors:  Reid R Hoshide; Heath Chung; Jinichi Tokeshi
Journal:  Hawaii Med J       Date:  2011-09

2.  Evolution of nasal carriage of methicillin-resistant coagulase-negative staphylococci in a remote population.

Authors:  David Lebeaux; François Barbier; Cécile Angebault; Lahcene Benmahdi; Etienne Ruppé; Benjamin Felix; Kevin Gaillard; Félix Djossou; Loïc Epelboin; Claire Dupont; Magaly Renard; Gilles Peroz; François Vandenesch; Michel Wolff; Antoine Andremont; Raymond Ruimy
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

3.  Carriage of Enterobacteria Producing Extended-Spectrum β-Lactamases and Composition of the Gut Microbiota in an Amerindian Community.

Authors:  María José Gosalbes; Jorge F Vázquez-Castellanos; Cécile Angebault; Paul-Louis Woerther; Etienne Ruppé; María Loreto Ferrús; Amparo Latorre; Antoine Andremont; Andrés Moya
Journal:  Antimicrob Agents Chemother       Date:  2015-11-09       Impact factor: 5.191

4.  Characterization of fecal extended-spectrum-β-lactamase-producing Escherichia coli in a remote community during a long time period.

Authors:  Paul-Louis Woerther; Cécile Angebault; Hervé Jacquier; Olivier Clermont; Assyia El Mniai; Brigitte Moreau; Félix Djossou; Gilles Peroz; François Catzeflis; Erick Denamur; Antoine Andremont
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

5.  Combating antimicrobial resistance: policy recommendations to save lives.

Authors:  Brad Spellberg; Martin Blaser; Robert J Guidos; Helen W Boucher; John S Bradley; Barry I Eisenstein; Dale Gerding; Ruth Lynfield; L Barth Reller; John Rex; David Schwartz; Edward Septimus; Fred C Tenover; David N Gilbert
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

6.  Is fecal carriage of extended-spectrum-β-lactamase-producing Escherichia coli in urban rats a risk for public health?

Authors:  Sebastian Guenther; Julia Wuttke; Astrid Bethe; Jirí Vojtech; Katharina Schaufler; Torsten Semmler; Rainer G Ulrich; Lothar H Wieler; Christa Ewers
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

Review 7.  The Traveling Microbiome.

Authors:  Mark S Riddle; Bradley A Connor
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

8.  Escherichia coli Population Structure and Antibiotic Resistance at a Buffalo/Cattle Interface in Southern Africa.

Authors:  Mathilde Mercat; Olivier Clermont; Méril Massot; Etienne Ruppe; Michel de Garine-Wichatitsky; Eve Miguel; Hugo Valls Fox; Daniel Cornelis; Antoine Andremont; Erick Denamur; Alexandre Caron
Journal:  Appl Environ Microbiol       Date:  2015-12-28       Impact factor: 4.792

9.  Detection of Antibiotic Resistance Genes in Source and Drinking Water Samples from a First Nations Community in Canada.

Authors:  Dinesh M Fernando; Hein Min Tun; Jenna Poole; Rakesh Patidar; Ru Li; Ruidong Mi; Geethani E A Amarawansha; W G Dilantha Fernando; Ehsan Khafipour; Annemieke Farenhorst; Ayush Kumar
Journal:  Appl Environ Microbiol       Date:  2016-07-15       Impact factor: 4.792

Review 10.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.